Barclays maintains an 'Equalweight' on Healthways (HWAY); 2Q In Line with Our Estimates, With Revenue Outlook Gaining Clarity
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Healthways (NASDAQ: HWAY) price target increased to $19.00.
Barclays analyst says, "While revenues and earnings ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "While revenues and earnings ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
